Article Type : Short communication
Authors : Kakutani H, Kato Y, Bando H, Fujikawa T, Kato Y, Yamamoto M, Okada K, Narutaki M, Kadota T, Kajimoto S, Ishikura K and Kawata T
Keywords : Skin perfusion pressure (SPP); Hemodialysis (HD); Peripheral artery disease (PAD); Ankle-brachial index (ABI); Wound, Ischemia, and foot Infection (WIfI)
Patients with hemodialysis (HD) have frequent peripheral artery disease (PAD). The possibility of PAD has been examined by ankle-brachial index (ABI), and recently useful measurement of skin perfusion pressure (SPP) has been introduced to clinical practice. Current study included 36 HD cases with 75.8 years old, and 13.3 years of HD period in average. By categorizing by HD duration, three group of 12 case each showed median value of 4.9, 10.6, 22.7 years, respectively. The latter group tends to show lower SPP compared with other two groups by quartile analysis. All groups showed significant correlation with SPP and amplitude
Authors and co-researchers have
continued various clinical practice and research for years. Among them, various
treatments are conducted including type 2 diabetes (T2D), cerebral vascular
accident (CVA), ischemic heart disease (IHD), peripheral artery disease (PAD),
chronic kidney disease (CKD), hemodialysis (HD), and other diseases [1]. Our
hospital has HD department, and lots of HD patients have been treated. They
have generalized problems in vascular diseases [2,3].
Especially, HD patients have frequent
PAD in lower extremities, leading to crucial condition. Most severe situation
would become acute limb ischemia (ALI) that progressively worsens within 2
weeks [4]. Due to comorbid conditions
including CVA, IHD, the mortality rate remains high at 15–20% [5]. Before ALI,
chronic vascular problem has been observed, which was formerly called as
arteriosclerosis obliterans (ASO), and recently called as lower extremity
artery disease (LEAD) [6]. For the diagnosis of LEAD, popular examination is
known for ankle-brachial index (ABI? [7]. Recent
trends introduced Wound, Ischemia, and foot Infection (WIfI) classification,
which is from the Society for Vascular Surgery WIFI [8]. It would be useful for
the management of PAD cases.
Furthermore, useful measurement of
skin perfusion pressure (SPP) has been recently introduced to clinical
practice. SPP refers to the perfusion pressure in the microcirculation of skin
tissue, and it seems to be an index for maintaining material exchange. SPP can
be applied for the assessment the severity of chronic limb-threatening ischemia
(CLTI) and to decision of treatment options [9]. Authors have reported several
articles about CKD, HD, and related clinical matters. We have tried to evaluate
the status of PAD for HD patients by using SPP examination. From our
experience, general data of SPP for HD patients with some related perspectives
will be described in this article.
Patients and Methods
In this study, patients have received
regular HD three times a week for years. We analyzed data from 41 consecutive
SPP tests that have been recently performed at Kanaiso Hospital. They received
SPP exams in right and left feet. Among them, 5 cases showed blank data of
either right or left foot because of probable occlusive status from their PAD
situation. We have omitted 5 cases, and 36 cases were investigated for
statistical examination, associated with complete data of plantar/dorsal sites
of right/left sides. Among 36 applicants, male and female were 24 and 12 cases,
respectively.
Methods included the measurement of
SPP by the clinical apparatus of PAD4000 developed by Kaneka Medical Product,
Japan, which is product No. 22500BZX00516000 [10]. It can measure 0.0-4.1% skin
perfusion stream, 0-250 mmHg as SSP, 0-80 mm of maximum amplitude, and 1-8 Hz
of responsive frequency as air volume pulse wave.
Ethical Standards
Current protocol complied with the
usual ethical guideline for Declaration of Helsinki [11]. In addition, some
comments were found with the protected regulation for human information. This
principle has been associated with the ethic regulation for actual practice and
research for human cases. Some guidelines are informed by Japanese Ministry. It
included the Ministry of Health, Labor and Welfare and the Ministry of
Education, Culture, Sports, Science Technology, Japan. The authors and
collaborators established the ethic committee for this patient, which is in
Kanaiso Hospital, Tokushima, Japan. The committee has clinical and also legal
personnel, including hospital director, internists, nurse, dietitian,
pharmacist, and also legal professional. These members have discussed in
satisfactory manner, agreed for the research protocol, and gained the written
informed consent from current case.
Results
Current study included 36 HD patients
(M/F 24/12), in which general data were analyzed. Their age showed 75.8 +/- 8.9
years old (mean +/- SD) with 76 years old in median. Detail quartile data of 36
cases were summarized in Table 1. The relationship between age and HD duration
period was calculated in Figure 1 with negative significant correlation
(p<0.05). The applicants were divided into 2 groups with 18 cases each
(Figure 2). Younger group with 49-75 years showed wider distribution of SPP
values than those of older group with 76-91 years. Furthermore, the applicants
were divided into 3 groups with 12 cases each by the HD duration years, in
which median value showed 4.9, 10.6 and 22.7 years, respectively (Figure 3).
In long HD group, SPP values showed
the tendency of lower SPP levels than standard range of 50 mmHg. By analyzing
the SPP value in left plantar and left amplitude level, short history (Hx)
group showed rather scattered distribution, and long Hx group showed small
narrower distribution (Figure 4).
Discussion
A meta-analysis with integrated data
of some cohort studies showed that decreased ABI (<0.90) would be 1.1% [7].
From international systematic review, PAD has some main risk factors leading to
LEAD, including smoking, age, diabetes, hypertension, dyslipidemia and CVA
[12]. Among these situations, SPP becomes a reliable biomarker [13]. The
interesting report has been found from an epidemiological study in Japan. It
was the large study for PAD, named as Surveillance of Cardiovascular Events in
Antiplatelet-Treated Arteriosclerosis Obliterans Patients in Japan (SEASON). As
a result, prevalence of risk factors for PAD was shown as follows: they are
16.2% for smoking, 61.5% for hypertension, 38.3% for diabetes, 38.8% for
dyslipidemia, 29.7% for heart disease, 17.1% for cerebrovascular disease, and
14.3% for CKD [14]. Using WLFI classification, the target limb is evaluated
based on three factors of tissue loss, ischemia, and foot infection [15]. CLTI
is diagnosed in adults who have been objectively diagnosed with LEAD and who
have a variety of clinical symptoms [16].
This study included HD patients
undergoing conventional standard treatment. To reflect the situation in daily
medical practice, the subjects included 41 HD patients who had undergone
continuous SPP examinations up to the present. However, five HD patients were
excluded from the analysis because data on both sides could not be obtained due
to PAD in the lower limbs. The data in this study were analyzed for cases with
all data available, and the average and median of all 36 cases are shown (Table
1).
Among the relationship between age
and HD duration period, several cases were far from the central distribution
(Figure 1). This would be due to the causative disease such as diabetes, CKD,
and other diseases, and the starting point of dialysis also differed greatly
from case to case. Therefore, the distribution of SPP would be wider in the
younger group (Figure 2). When divided into three groups by continuing HD
period, SPP value and amplitude degree also decreased due to long-term HD (Figures
3,4). These results indicate that the amount of SPP and amplitude data provided
may gradually decrease with the prolongation of HD treatment.
Concerning our current data, recent
similar reports are observed. For several years, discussion has been observed
concerning the cut-off degree of SPP measurements, that is usually 50 mmHg. By
a novel probe of laser Doppler flowmetry (LD), the diagnosis for PAD was
studied for 40 cases. As a result, SPP more than 30 mmHg was considered to be
adequate for clinical relevant cut-off level [17]. Mutual correlation was
studied among SPP, brachial-ankle pulse wave velocity (baPWV), ABI and
flow-mediated dilation (FMD) in 80 HD patients [18]. Cases with ABI < 0.95
showed significant lower SPP of both dorsal/plantar feet. Low FMD had
significantly lower TG (p=0.033) and higher Ca-P product (p=0.018). Significant
associations were observed between dorsal SPP and low ABI (p=0.001)/low baPWV
(p=0.036). In contrast, low plantar SPP showed low HDL (p=0.016) and lower ABI
(p=0.002). For the relationship between SPP and sarcopenia, 102 T2D cases were
investigated [19]. The prevalence of sarcopenia was 11.8%. The ratio of cases
with SPP ?50 mmHg showed 3-folds more than cases with SPP > 50 mmHg as 28.6%
vs 9.1%. By multiple logistic regression analysis, cases of SPP ?50 mmHg showed
sarcopenia by odds ratio (ORs) of 4.1.
Some limitations may exist in this
report. Current HD patients have various background and comorbidities, and then
rather wider distribution in the examined correlation would be related to these
aspects. Moreover, the measured results of SPP seem to be fluctuated by the
timing of the SPP exam [20]. Consequently, we will follow the future progress
for SSP measurement in HD patients with careful attention.
In summary, clinical research of SSP
in HD cases with various perspectives was described in the article. PAD in HD
would be crucial problem, and adequate management for HD cases will be
continued for long. It is expected that this research gives benefit for HD and
CKD practice in the future.
Conflict of Interest
The authors declare no conflict of
interest.
Funding
There was no funding received for
this paper.